首页> 美国卫生研究院文献>Clinical and Experimental Hepatology >Study of Dickkopf-1 (DKK-1) in patients with chronic viral hepatitis C-related liver cirrhosis with and without hepatocellular carcinoma
【2h】

Study of Dickkopf-1 (DKK-1) in patients with chronic viral hepatitis C-related liver cirrhosis with and without hepatocellular carcinoma

机译:肝细胞癌慢性病毒丙型肝炎患者Dickkopf-1(DKK-1)研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Dickkopf-1 (DKK-1) is a secreted protein which acts as an inhibitor of Wnt/β-catenin signaling. DKK-1 was found to be a helpful biomarker for many cancers including hepatocellular carcinoma (HCC). HCC is multifactorial in origin and its main etiology in Egypt is attributed to chronic hepatitis C virus (HCV) infection. Objectives: To assess the serum level and diagnostic performance of DKK-1 and α-fetoprotein (AFP) in Egyptian patients with chronic HCV-related liver cirrhosis with and without HCC.
机译:Dickkopf-1(DKK-1)是一种分泌的蛋白质,其作为Wnt /β-连环蛋白信号传导的抑制剂。发现DKK-1是有用的生物标志物,用于许多癌症,包括肝细胞癌(HCC)。 HCC是原产地的多因素,其主要病因归因于慢性丙型肝炎病毒(HCV)感染。目的:评估埃及慢性HCV相关肝硬化患者DKK-1和α-胎蛋白(AFP)的血清水平和诊断性能,慢性HCV相关肝肝硬化和没有HCC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号